PCMA federal affairs
Executive Summary
Missy Jenkins joins Pharmaceutical Care Management Association as VP-federal affairs. Jenkins was previously with the Pharmaceutical Research & Manufacturers of America's lobbying team (1"The Pink Sheet" June 16, 2003, In Brief). PCMA has revamped its public affairs and lobbying staffs and taken a more aggressive stance on Capitol Hill since Mark Merritt became CEO in March ("The Pink Sheet" May 19, 2003, p. 29). Merritt also moved to PCMA from PhRMA...
You may also be interested in...
PhRMA loses GOP lobbyist
Pharmaceutical Research & Manufacturers of America Senior Director-Federal Affairs Missy Jenkins is leaving the trade association after two years. Jenkins, whose Capitol Hill experience includes serving on the staff of former Rep. Newt Gingrich (R-Ga.) and former Sen. Alan Simpson (R-Wyo.), is understood to have resigned from PhRMA on June 6. Two other members of PhRMA's federal affairs team left earlier this year to join member companies. Sonya Sotak (formerly a staffer to Sen. John McCain) joined the Lilly D.C. office, while Jacqueline Pomfret (formerly with AAHP) joined AstraZeneca (1"The Pink Sheet" May 12, 2003, p. 32)...
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.